Quantcast

FDA rejects painkiller Arcoxia, Merck's Vioxx successor

The Food and Drug Administration rejected Merck & Co.'s request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drugmaker said Friday.

Leave a Reply

Your email address will not be published. Required fields are marked *

*